Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
MeritCare Medical Group
837
mi
from 43215
Fargo, ND
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
MeritCare Medical Group
837
mi
from 43215
Fargo, ND
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Altru Cancer Center at Altru Hospital
885
mi
from 43215
Grand Forks, ND
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Altru Cancer Center at Altru Hospital
885
mi
from 43215
Grand Forks, ND
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Wood County Oncology Center
103
mi
from 43215
Bowling Green, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Wood County Oncology Center
103
mi
from 43215
Bowling Green, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Blanchard Valley Medical Associates
80
mi
from 43215
Findlay, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Blanchard Valley Medical Associates
80
mi
from 43215
Findlay, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Fremont Memorial Hospital
95
mi
from 43215
Fremont, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Fremont Memorial Hospital
95
mi
from 43215
Fremont, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Kenton Oncology, Incorporated
56
mi
from 43215
Kenton, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Kenton Oncology, Incorporated
56
mi
from 43215
Kenton, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Lima Memorial Hospital
76
mi
from 43215
Lima, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Lima Memorial Hospital
76
mi
from 43215
Lima, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Northwest Ohio Oncology Center
116
mi
from 43215
Maumee, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Northwest Ohio Oncology Center
116
mi
from 43215
Maumee, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
St. Luke's Hospital
116
mi
from 43215
Maumee, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
St. Luke's Hospital
116
mi
from 43215
Maumee, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
St. Charles Mercy Hospital
118
mi
from 43215
Oregon, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
St. Charles Mercy Hospital
118
mi
from 43215
Oregon, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Toledo Clinic - Oregon
118
mi
from 43215
Oregon, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Toledo Clinic - Oregon
118
mi
from 43215
Oregon, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Firelands Regional Medical Center
103
mi
from 43215
Sandusky, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Firelands Regional Medical Center
103
mi
from 43215
Sandusky, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
North Coast Cancer Care, Incorporated
103
mi
from 43215
Sandusky, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
North Coast Cancer Care, Incorporated
103
mi
from 43215
Sandusky, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Promedica Cancer Center at Flower Hospital
126
mi
from 43215
Sylvania, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Promedica Cancer Center at Flower Hospital
126
mi
from 43215
Sylvania, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Mercy Hospital of Tiffin
80
mi
from 43215
Tiffin, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Mercy Hospital of Tiffin
80
mi
from 43215
Tiffin, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Toledo Hospital
121
mi
from 43215
Toledo, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Toledo Hospital
121
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
St. Vincent Mercy Medical Center
121
mi
from 43215
Toledo, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
St. Vincent Mercy Medical Center
121
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Medical College of Ohio Cancer Institute
117
mi
from 43215
Toledo, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Medical College of Ohio Cancer Institute
117
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
CCOP - Toledo Community Hospital
120
mi
from 43215
Toledo, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
CCOP - Toledo Community Hospital
120
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Toledo Clinic, Incorporated - Main Clinic
124
mi
from 43215
Toledo, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Toledo Clinic, Incorporated - Main Clinic
124
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Toledo Surgical Specialists
124
mi
from 43215
Toledo, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Toledo Surgical Specialists
124
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Fulton County Health Center
125
mi
from 43215
Wauseon, OH
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Fulton County Health Center
125
mi
from 43215
Wauseon, OH
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Natalie Warren Bryant Cancer Center at St. Francis Hospital
752
mi
from 43215
Tulsa, OK
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Natalie Warren Bryant Cancer Center at St. Francis Hospital
752
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
397
mi
from 43215
Allentown, PA
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
397
mi
from 43215
Allentown, PA
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Geisinger Medical Center
344
mi
from 43215
Danville, PA
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Geisinger Medical Center
344
mi
from 43215
Danville, PA
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Geisinger Medical Group
277
mi
from 43215
State College, PA
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Geisinger Medical Group
277
mi
from 43215
State College, PA
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
385
mi
from 43215
Wilkes-Barre, PA
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
385
mi
from 43215
Wilkes-Barre, PA
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Rose Ramer Cancer Clinic at Anderson Area Medical Center
377
mi
from 43215
Anderson, SC
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Rose Ramer Cancer Clinic at Anderson Area Medical Center
377
mi
from 43215
Anderson, SC
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
CCOP - Upstate Carolina
351
mi
from 43215
Spartanburg, SC
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
CCOP - Upstate Carolina
351
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
349
mi
from 43215
Spartanburg, SC
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
349
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Avera McKennan Hospital and University Health Center
747
mi
from 43215
Sioux Falls, SD
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Avera McKennan Hospital and University Health Center
747
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Medical X-Ray Center, P. C.
747
mi
from 43215
Sioux Falls, SD
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Medical X-Ray Center, P. C.
747
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Sioux Valley Hospital at University of South Dakota Medical Center
1160
mi
from 43215
Sioux Falls, SD
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Sioux Valley Hospital at University of South Dakota Medical Center
1160
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Green Bay Oncology, Limited at St. Vincent Hospital
403
mi
from 43215
Green Bay, WI
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Green Bay Oncology, Limited at St. Vincent Hospital
403
mi
from 43215
Green Bay, WI
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Green Bay Oncology, Limited at St. Mary's Hospital
407
mi
from 43215
Green Bay, WI
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Green Bay Oncology, Limited at St. Mary's Hospital
407
mi
from 43215
Green Bay, WI
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
St. Mary's Hospital Medical Center - Green Bay
407
mi
from 43215
Green Bay, WI
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
St. Mary's Hospital Medical Center - Green Bay
407
mi
from 43215
Green Bay, WI
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
St. Vincent Hospital Regional Cancer Center
403
mi
from 43215
Green Bay, WI
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
St. Vincent Hospital Regional Cancer Center
403
mi
from 43215
Green Bay, WI
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Green Bay Oncology, Limited - Oconto Falls
427
mi
from 43215
Oconto Falls, WI
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Green Bay Oncology, Limited - Oconto Falls
427
mi
from 43215
Oconto Falls, WI
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Green Bay Oncology, Limited - Sturgeon Bay
405
mi
from 43215
Sturgeon Bay, WI
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Green Bay Oncology, Limited - Sturgeon Bay
405
mi
from 43215
Sturgeon Bay, WI
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Welch Cancer Center at Sheridan Memorial Hospital
1261
mi
from 43215
Sheridan, WY
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Welch Cancer Center at Sheridan Memorial Hospital
1261
mi
from 43215
Sheridan, WY
Click here to add this to my saved trials
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated:  7/12/2016
Allan Blair Cancer Centre at Pasqua Hospital
1268
mi
from 43215
Regina,
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma
Status: Enrolling
Updated: 7/12/2016
Allan Blair Cancer Centre at Pasqua Hospital
1268
mi
from 43215
Regina,
Click here to add this to my saved trials
Internet-Based Weight-Loss Program for Colorectal Cancer Survivors
Internet Weight Loss Intervention for Individuals Diagnosed With Colorectal Cancer
Status: Enrolling
Updated:  7/13/2016
Rutgers Cancer Institute of New Jersey
453
mi
from 43215
New Brunswick, NJ
Internet-Based Weight-Loss Program for Colorectal Cancer Survivors
Internet Weight Loss Intervention for Individuals Diagnosed With Colorectal Cancer
Status: Enrolling
Updated: 7/13/2016
Rutgers Cancer Institute of New Jersey
453
mi
from 43215
New Brunswick, NJ
Click here to add this to my saved trials
Internet-Based Weight-Loss Program for Colorectal Cancer Survivors
Internet Weight Loss Intervention for Individuals Diagnosed With Colorectal Cancer
Status: Enrolling
Updated:  7/13/2016
Fox Chase Cancer Center
420
mi
from 43215
Philadelphia, PA
Internet-Based Weight-Loss Program for Colorectal Cancer Survivors
Internet Weight Loss Intervention for Individuals Diagnosed With Colorectal Cancer
Status: Enrolling
Updated: 7/13/2016
Fox Chase Cancer Center
420
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated:  7/13/2016
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated: 7/13/2016
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated:  7/13/2016
Stanford University
2100
mi
from 43215
Stanford, CA
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated: 7/13/2016
Stanford University
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated:  7/13/2016
Moffitt Cancer Center and Research Institute
824
mi
from 43215
Tampa, FL
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated: 7/13/2016
Moffitt Cancer Center and Research Institute
824
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas
Observational - SNP Array Analysis of Undifferentiated Sarcomas
Status: Enrolling
Updated:  7/13/2016
Children's Oncology Group
1957
mi
from 43215
Monrovia, CA
Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas
Observational - SNP Array Analysis of Undifferentiated Sarcomas
Status: Enrolling
Updated: 7/13/2016
Children's Oncology Group
1957
mi
from 43215
Monrovia, CA
Click here to add this to my saved trials
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma
Observational - Identifying and Validating Novel Mechanisms of Radiation Resistance in Rhabdomyosarcoma
Status: Enrolling
Updated:  7/13/2016
Children's Oncology Group
1957
mi
from 43215
Monrovia, CA
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma
Observational - Identifying and Validating Novel Mechanisms of Radiation Resistance in Rhabdomyosarcoma
Status: Enrolling
Updated: 7/13/2016
Children's Oncology Group
1957
mi
from 43215
Monrovia, CA
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Scottsdale Oncology Program
1644
mi
from 43215
Scottsdale, AZ
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Scottsdale Oncology Program
1644
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials